Encompass Health (EHC) Cash & Equivalents (2009 - 2026)

Encompass Health (EHC) has reported Cash & Equivalents for 18 consecutive years, with $110.5 million the latest figure, recorded in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $110.5 million, up 15.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $110.5 million (up 15.34% YoY), and the FY2025 annual result was $72.2 million, down 15.46% from the prior year.
• Cash & Equivalents was $110.5 million for Q1 2026 at Encompass Health, up from $72.2 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $154.4 million in Q2 2024 and troughed at $21.8 million in Q4 2022.
• Average Cash & Equivalents over 5 years is $94.9 million, with a median of $95.8 million recorded in 2025.
• Year-over-year, Cash & Equivalents soared 216.97% in 2023 and sank 67.05% in 2025.
• Over 5 years, Cash & Equivalents stood at $21.8 million in 2022, then jumped by 216.97% to $69.1 million in 2023, then rose by 23.59% to $85.4 million in 2024, then retreated by 15.46% to $72.2 million in 2025, then jumped by 53.05% to $110.5 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $110.5 million in Q1 2026, $72.2 million in Q4 2025, and $48.7 million in Q3 2025.